These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7570508)

  • 1. [Estrogen receptor studies in breast cancer based on histological material. Correlation with results from needle biopsy aspirates and pS2 protein determination].
    Sauer T; Naess O
    Tidsskr Nor Laegeforen; 1995 Sep; 115(23):2881-3. PubMed ID: 7570508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the pS2 protein and correlation with estrogen receptor status in fine-needle aspirates from breast carcinomas.
    Sauer T; Naess O
    Diagn Cytopathol; 1994; 11(2):165-7. PubMed ID: 7813365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of pS2-protein in breast cancer].
    Kawabata K; Watanabe K; Ozaki S
    Rinsho Byori; 1996 Jul; 44(7):647-52. PubMed ID: 8741495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of pS2 protein in breast cancer.
    Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Neuhaus W; Möbus V; Schaeffer HJ
    Arch Gynecol Obstet; 1993; 253(4):183-92. PubMed ID: 8161252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.
    Detre S; King N; Salter J; MacLennan K; McKinna JA; Dowsett M
    J Clin Pathol; 1994 Mar; 47(3):240-4. PubMed ID: 8163696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns.
    Dookeran KA; Rye PD; Dearing SJ; Walker RA
    J Pathol; 1993 Oct; 171(2):123-9. PubMed ID: 8283349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.
    Marsigliante S; Biscozzo L; Correale M; Paradiso A; Leo G; Abbate I; Dragone CD; Storelli C
    Br J Cancer; 1994 Mar; 69(3):550-4. PubMed ID: 8123486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the cytosolic content of the pS2 protein in breast cancer].
    Tamargo F; Vizoso F; Lamelas ML; Rodil A; Vérez P; Raigoso P; Mulero M; Vázquez J; Roiz C; Allende MT
    Rev Esp Med Nucl; 2002 Feb; 21(1):28-33. PubMed ID: 11820999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours.
    Pallud C; Le Doussal V; Pichon MF; Prud'homme JF; Hacene K; Milgrom E
    Histopathology; 1993 Sep; 23(3):249-56. PubMed ID: 8225243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors].
    Díez Gibert O; Machuca I; Sebastián MA; Rosel P; Navarro MA
    Med Clin (Barc); 1996 Jun; 107(3):90-2. PubMed ID: 8754494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of estrogen receptors in aspirates from needle biopsies of breast carcinomas. Correlation to a biochemical method].
    Sauer T; Naess O; Kåresen R; Jacobsen U; Amlie E; Haug E
    Tidsskr Nor Laegeforen; 1994 Apr; 114(9):1053-5. PubMed ID: 8009516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.
    Hodi Z; Chakrabarti J; Lee AH; Ronan JE; Elston CW; Cheung KL; Robertson JF; Ellis IO
    J Clin Pathol; 2007 Mar; 60(3):299-302. PubMed ID: 16731591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.
    Cappelletti V; Coradini D; Scanziani E; Benini E; Silvestrini R; Di Fronzo G
    Eur J Cancer; 1992; 28A(8-9):1315-8. PubMed ID: 1515241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [pS2 protein and breast cancer].
    Torre EA; Fulco RA
    Minerva Ginecol; 1995 Dec; 47(12):553-6. PubMed ID: 8720977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival.
    Thor AD; Koerner FC; Edgerton SM; Wood WC; Stracher MA; Schwartz LH
    Breast Cancer Res Treat; 1992; 21(2):111-9. PubMed ID: 1627814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemistry in the assessment of pS2 protein expression in fine needle aspiration cytology from breast carcinoma.
    Ibrahim NB; Padfield CJ; Rees EJ; Wilson Y; Cawthorn SJ
    Cytopathology; 1993; 4(6):323-30. PubMed ID: 8110971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activity.
    Correale M; Paradiso A; Abbate I; Mangia A; Dragone CD; Tedone T; Filotico R; Schittulli F; De Lena M
    Tumour Biol; 1993; 14(1):30-7. PubMed ID: 8493448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of pS2 estrogen-inducible protein in primary breast cancer.
    Horiguchi J; Iino Y; Takei H
    Oncology; 1996; 53(1):12-5. PubMed ID: 8570124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High positive rate of pS2 expression in forefront intraductal cancerous area in breast cancer.
    Yamakawa T; Morimoto T; Sasa M; Numoto S; Monden Y
    Jpn J Cancer Res; 1995 Nov; 86(11):1035-40. PubMed ID: 8567393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.